Position in JNJ
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$1,073,785
-$67,260 QoQ
Shares Held
4,228
-9.4% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
1.05%
of 13F equity value
Holder Rank
#2,954
of 4,664 holders
Holding Since
Dec 2025
3 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Diesslin Group, Inc. holds $1,925,401 across 2 Drug Manufacturers - General names. JNJ ranks #1 (55.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
This page
|
4,228 | $1,073,785 | |
| 2 | NVS |
Novartis AG
|
5,434 | $851,616 |
All Filings in JNJ
Export CSV
3 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,073,785 | 4,228 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $1,141,045 | 4,668 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $1,127,877 | 5,450 | Shares | Sole | 2026-02-25 | |
| No filing history on record for this holder in this stock. | ||||||